Syantra is a precision biotechnology company focused on revolutionizing cancer detection and treatment. Their proprietary Onco-ID™ platform utilizes a blood-based liquid biopsy to detect early signs of cancer by analyzing shifts in the body's immune system and physiological responses, rather than directly looking for cancer cells. This approach aims to enable earlier diagnosis and more effective interventions.